For help on how to get the results you want, see our search tips.
379 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Natpar (updated)
parathyroid hormone, Hypoparathyroidism
Date of authorisation: 24/04/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 14/10/2019
-
List item
Human medicine European public assessment report (EPAR): Symkevi (updated)
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, , Revision: 2, Authorised, Last updated: 14/10/2019
-
List item
Human medicine European public assessment report (EPAR): Truxima (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Wegener Granulomatosis, Leukemia, Lymphocytic, Chronic, B-Cell, Microscopic Polyangiitis
Date of authorisation: 17/02/2017,, 
, Revision: 9, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): EndolucinBeta (updated)
lutetium (177 Lu) chloride, Radionuclide Imaging
Date of authorisation: 06/07/2016,, Revision: 5, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Symtuza (updated)
darunavir, cobicistat, emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/09/2017,, Revision: 7, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015,, Revision: 9, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo (updated)
telotristat etiprate, Carcinoid Tumor, Neuroendocrine Tumors
Date of authorisation: 17/09/2017,, , Revision: 6, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Pelmeg (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, , Revision: 1, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Opdivo (updated)
nivolumab, Melanoma, Hodgkin Disease, Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 19/06/2015,, Revision: 27, Authorised, Last updated: 11/10/2019
-
List item
Human medicine European public assessment report (EPAR): Gardasil 9 (updated)
human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed), Condylomata Acuminata, Papillomavirus Infections, Immunization, Uterine Cervical Dysplasia
Date of authorisation: 09/06/2015,, Revision: 10, Authorised, Last updated: 10/10/2019
-
List item
Human medicine European public assessment report (EPAR): Filgrastim Hexal (updated)
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 06/02/2009,, Revision: 16, Authorised, Last updated: 10/10/2019
-
List item
Human medicine European public assessment report (EPAR): Ninlaro (updated)
ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016,, , , Revision: 5, Authorised, Last updated: 10/10/2019
-
List item
Human medicine European public assessment report (EPAR): Epclusa (updated)
Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016,, 
, Revision: 9, Authorised, Last updated: 10/10/2019
-
List item
Human medicine European public assessment report (EPAR): Mulpleo (previously Lusutrombopag Shionogi) (updated)
Lusutrombopag, Thrombocytopenia
Date of authorisation: 18/02/2019,, Revision: 2, Authorised, Last updated: 10/10/2019
-
List item
Human medicine European public assessment report (EPAR): Besponsa (updated)
inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 28/06/2017,, , Revision: 4, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Lokelma (updated)
sodium zirconium cyclosilicate, Hyperkalemia
Date of authorisation: 22/03/2018,, Revision: 3, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Odomzo (updated)
sonidegib diphosphate, Carcinoma, Basal Cell
Date of authorisation: 14/08/2015,, Revision: 7, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Fexeric (updated)
ferric citrate coordination complex, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 23/09/2015,, Revision: 2, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Epoetin Alfa Hexal (updated)
epoetin alfa, Anemia, Kidney Failure, Chronic, Cancer
Date of authorisation: 27/08/2007,, Revision: 22, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Respreeza (updated)
alpha1-proteinase inhibitor (human), Genetic Diseases, Inborn, Lung Diseases
Date of authorisation: 20/08/2015,, Revision: 6, Authorised, Last updated: 09/10/2019
-
List item
Human medicine European public assessment report (EPAR): Nivestim (updated)
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 07/06/2010,, Revision: 20, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Duzallo (updated)
allopurinol, lesinurad, Gout
Date of authorisation: 23/08/2018,, Revision: 1, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Lonsurf (updated)
trifluridine, tipiracil hydrochloride, Colorectal Neoplasms
Date of authorisation: 25/04/2016,, Revision: 4, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Jinarc (updated)
Tolvaptan, Polycystic Kidney, Autosomal Dominant
Date of authorisation: 27/05/2015,, Revision: 13, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Abseamed (updated)
epoetin alfa, Anemia, Kidney Failure, Chronic, Cancer
Date of authorisation: 27/08/2007,
Date of refusal: 18/06/2009,, Revision: 22, Authorised, Last updated: 08/10/2019